Riding stock crest, Alexion looks to push the envelope
By Marie Powers
Wednesday, January 15, 2014
SAN FRANCISCO – Alexion Pharmaceuticals Inc. CEO Leonard Bell suggested Wednesday during his presentation at the J.P. Morgan (JPM) Healthcare Conference that the company’s investment in Moderna Therapeutics Inc. might not be its last significant business development move in 2014.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.